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Available online 14 July 2016Purpose: To develop an in-vivo imaging method for the measurement of dorsal-root-ganglia-(DRG) perfusion, to
establish its normal values in patients without known peripheral nerve disorders or radicular pain syndromes
and to determine the physiological spatial perfusion pattern within the DRG.
Methods: This prospective study was approved by the institutional ethics committee and written informed con-
sent was obtained from all participants. 46 (24 female, 22 male, mean age 46.0 ± 15.2 years) subjects without
known peripheral neuropathies or pain syndromes were examined by a 3 Tesla MRI scanner (Magnetom
VERIO or TRIO, Siemens AG, Erlangen, Germany) with a VIBE (Volume-Interpolated-Breathhold-Examination)
dynamic-contrast-enhanced (DCE) T1-w-sequence (TR/TE 3.3/1.11 ms; 24 slices; voxel resolution
1.3 × 1.3 × 3.0 mm3) covered the pelvis from the upper plate of the 5th lumbar vertebra to the 2nd sacral verte-
bra. Transfer-constant (Ktrans) and interstitial-volume-fraction (interstitial-leakage-fraction, Ve) were modeled
for the DRG and spinal nerve by applying the Tofts-model. Statistical analyses included pairwise comparisons
of L5/S1 DRG vs. spinal nerve. Furthermore, distinct physiological zones within the S1 DRG were compared
(cell body rich area (CBRA) vs. nerve ﬁber rich area (NFRA)).
Results: DRG showed a signiﬁcantly increased permeability compared to spinal nerve (Ktrans 3.8 ± 1.5 10−3/min
vs. 1.6 ± 0.9 10−3/min, p-value: b0.001) combined with an increased interstitial leakage of contrast agent into
the extravascular-extracellular-space (Ve 38.1 ± 19.2% vs. 17.3 ± 9.9%, p-value: b0.001).
Parameters showed no statistically signiﬁcant difference on DRG-level (L5 vs. S1; p-value: 0.62 (Ktrans); 0.17
(Ve)) and -side (left vs. right; p-value: 0.25 (Ktrans); 0.79 (Ve)).
Female gender was associated with a signiﬁcantly increased permeability (Ktrans female 4.3 ± 1.4 10−3/min vs.
male 3.4 ± 0.9 10−3/min, p-value: b0.05) but no statistically signiﬁcant differences in interstitial leakage (Ve fe-
male 40.1 ± 14,1% vs. male 34.5 ± 17.4%, p-value: 0.24).
DRG showeddistinct spatial distribution patterns of perfusion: Ktrans and Vewere signiﬁcantly higher in the CBRA
than in the NFRA (Ktrans 4.4 ± 1.8 10−3/min vs. 1.7 ± 1.2 10−3/min, p-value: b0.001 and Ve 40.9 ± 21.3% vs.
15.1 ± 11.7%, p-value: b0.001).
Conclusion:Non-invasive and in-vivomeasurement of human DRG perfusion byMRI is a feasible technique. DRG
show substantially higher permeability and interstitial leakage than spinal nerves. Even distinct physiological
perfusion patterns for differentmicrostructural compartments could be observed within the DRG. The technique
may become particularly useful for future research on the poorly understood human sensory neuropathies and
pain syndromes.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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The dorsal-root-ganglia (DRG) represent dense accumulations of
nerve cell bodies of the primary sensory neurons and are locateddy rich area; NFRA, nerve ﬁber
mic-contrast-enhanced; VIBE,
region of interest; AIF, arterial
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. This is an open access article underpairwise in, or closely adjacent to the intervertebral foramina along
the spine. The prime electrophysiological function of the DRG is to re-
ceive the bulk afferent sensory input from the PNS and relay it to the
CNS.
A nerve ﬁber rich area (NFRA), which is located more centrally, con-
tains the incoming and outgoing nerve ﬁbers (Fig. 1), whereas the pe-
ripheral regions of the DRG are denominated cell body rich area
(CBRA) for containing the densely accumulated cell bodies of the
pseudounipolar, sensory neurons, which are embedded in a dense cap-
illary network (Jimenez-Andrade et al., 2008). Blood supply to the DRG
is provided by the spinal branch of the dorsal trunk of the segmental ar-
teries. After penetrating the ganglionic capsule, the arteries give rise to athe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Dense vascularization of theperipheral CBRA compared to the central NFRA. Left Confocalmicrograph of amouse L4DRG labeledwith the endothelial cellmarker CD31 showing the
marked difference in the density of the vascular supply of the densely arranged sensory ganglia (CBRA,white arrows) as compared to the corresponding entering/exiting spinal nerve and
ventral/dorsal roots (ventral root, dorsal root, spinal nerve: NFRA,white arrowheads). 280 optical sections acquired at 0.5 μmz-plane intervals; z stack thickness 140 μm. Scale bar 100 μm.
Right Bright-ﬁeld photomicrograph of a whole-mount L4 DRG for anatomical reference. This ﬁgure is used with permission of BioMed Central Ltd. (Jimenez-Andrade et al., 2008).
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the ganglion and branching into intraganglionic blood vessels
(Kobayashi et al., 2010). The regulation of blood ﬂow to the DRG is
achieved by muscular sphincters at strategic locations along the arteri-
ole trunks and their branchingpoints, to adjustﬂow to varying function-
al and metabolic demand (Kobayashi et al., 2010).
While the peripheral nervous system (PNS) generally has a tight
blood-nerve interface similar to the blood-brain-barrier (Weerasuriya
& Mizisin, 2011), the DRG are intensely vascularized organs with high
permeability between blood and nervous tissue (Jimenez-Andrade
et al., 2008; Hirakawa et al., 2004; Jacobs, 1978; Anzil et al., 1976; Jacobs
et al., 1976). This exception to the otherwise restricted permeability of
the PNS is potentially of high clinical relevance, because of the vulnera-
bility to low and high molecular weight neurotoxic substances
(Cavanagh, 1973; Cho, 1977; London & Albers, 2007; Le Quesne &
McLeod, 1977; Viaene et al., 1999; Ikeda et al., 1973) as well as to
toxic metabolites in drug- or metabolic-induced neuropathies (Lee &
Swain, 2006; Quasthoff & Hartung, 2002; Mielke et al., 2006; Pignata
et al., 2006; Pardo et al., 2001; Pettersen et al., 2006; McArthur et al.,
2005; Berger et al., 1993; Keswani et al., 2002; Nicholas et al., 2007a;
Nicholas et al., 2007b; Rahman et al., 2016).
In the CNS it is ﬁrmly established that an increased neural activity is
accompanied by an elevated, measurable oxygenation, blood volume
and ﬂow (Logothetis & Pfeuffer, 2004). Therefore it is likely, that partic-
ularly the increased activity of DRG neurons, which may especially
occur in pathological conditions of increased excitability and activation
(Xiao et al., 2016; Hogan, 2007; Sapunar et al., 2005; Zhang et al., 2004),
also leads to increasing demands in DRG perfusion. Furthermore, the
DRG plays an increasingly important role in the treatment of pain syn-
dromes and neuropathic pain as a target of electrical neurostimulation
(Pei et al., 2015; Forget et al., 2015; Eldabe et al., 2015; Van Buyten
et al., 2015; Liem et al., 2013; Koopmeiners et al., 2013).
Current knowledge about DRG perfusion is limited and comes from
experimental animal studies only (Jimenez-Andrade et al., 2008;
Kobayashi et al., 2010). Despite the potential physiological and clinical
relevance, to the best of our knowledge, in-vivo measurements in
humans have not been reported so far.
Dynamic-contrast-enhanced (DCE) methods of MRI perfusion have
long been utilized for the clinical and functional imaging investigation
of the CNS. These methods have only recently been tested for the PNS
targeting the trunks of peripheral nerve at the proximal extremities
(Baumer et al., 2014). DCE MRI can be used for the calculation of perfu-
sion parameters such as the interstitial leakage of contrast agent (Ve)
and blood-tissue permeability (Ktrans), providing functional in-vivo in-
formation that is otherwise not available in humans (Cuenod &
Balvay, 2013; Sourbron, 2010). In this study we developed a DCE MRImethod dedicated to the quantitative measurement of DRG perfusion
and applied this method in patients without peripheral neuropathies
or pain syndromes.
Patients and methods
Clinical and demographic patient data
This study was approved by the institutional ethics board (S398-
2012) and written informed consent was obtained from all patients.
Overall, we included 46 patients (24 female, 22 male, age 46.0 ±
15.2 years) for whom a contrast-enhanced examination of the spine
was indicated for reasons not pertaining to any peripheral nervous sys-
tem disorder (spinalMRI to rule outmetastases, spinal tumors,multiple
sclerosis, spinal hemorrhage or fractures of a lumbar vertebra). Patients
with symptoms suggestive of any peripheral neuropathy or
radiculopathy were explicitly excluded from the study.
Imaging
Examinations were conducted at a 3 Tesla MRI scanner (Magnetom
VERIO or TRIO, Siemens AG, Erlangen, Germany) between 7/2015 and
12/2015. The position of the imaging slab was chosen so that its upper
edge was aligned in parallel with the upper plate of the 5th lumbar ver-
tebra. Before contrast agent administration, T1-weighted volumetric-
interpolated-breathhold-examination (VIBE) sequences with 5°, 8°,
11°, 14° and 17° ﬂip angle were acquired. Then, a T1-weighted,
dynamic-contrast-enhanced (DCE) VIBE sequence was acquired with
the following sequence parameters: TR/TE 3.3/1.11 ms; ﬂip angle 15°;
24 slices; resolution 1.3 × 1.3 × 3.0 mm3. The contrast agent (Dotarem,
Guerbet, France) was administered intravenously at the beginning of
the third frame of the sequence at the standard concentration of
0.1 mmol/kg with a ﬂow rate of 3.5 ml/s by automated injection. A
total of 24 frames were recorded with a rate of 7.46 s/frame. A 15-
channel receive/transmit spine coil and an 8-channel receive body ﬂex
coil (Siemens) were used.
Quantitative image analysis
Quantitative image analysis was performed using the commercially
available software plug-in IB DCE 1.2 (Imaging Biometrics, Elm Grove,
USA) to Osirix (Pixmeo, Bernex, Switzerland). Image masks were ob-
tained by manual segmentation around the contour of the L5 and S1
DRG, which were reliably visible in the anatomical, T1-weighted non-
enhanced image (Fig. 2). As internal control, the 5th lumbar spinal
nerve on the right side at a presacral localization was likewise
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in the same imaging slab as the L5 and S1 DRG. Additional regions-of-
interests (ROIs) were placed in the common iliac artery to obtain
time-signal curves needed to deﬁne the arterial input function (AIF)
and to detect the time point of bolus arrival in the lumbar region.
Since it is not possible to differentiate the central (NFRA) and peripheral
(CBRA) zone on conventional MR images, further masks were obtained
by deﬁning these areas on the Ktrans/Ve maps which were rendered
voxel-wise as described below.
Voxel-wise modeling of Ktrans and Ve
The Tofts model is the most common pharmacokinetic model as-
suming a tissue compartment in addition to a vascular compartment.
Given the Gadolinium (Gd) concentration as a function of time, it
models how the contrast agent distributes in the body and how this de-
pends on characteristics of DRG and spinal nerve perfusion. Ktrans
(expressed in min−1) is the most important and signiﬁcant tissue de-
pendent parameter in Tofts. It assesses either plasma ﬂow in ﬂow-
limited scenarios or tissue permeability in permeability-limited scenar-
ios for the uptake. In mixed scenarios it indicates a combination of the
ﬂow and permeability properties of the tissue.
Since the applied contrast agent Dotarem is of small molecular size
(559 Da, Gd-DOTA), its leakage from the capillaries into the extracellu-
lar, extravascular space (EES) is diffusive and hence reversible; it is
therefore proportional to the difference in concentrations between the
two compartments and Ktrans is the constant of this proportionality.Fig. 2. Image acquisition, segmentation and perfusion parameter calculation. Quantitative analy
as well as the right spinal nerve L5 in axial T1-VIBE source images as illustrated in the upper le
values for Ktrans and Ve.Furthermore themodeling reveals the interstitial blood volume fraction
Ve (interstitial leakage fraction, expressed in %).
Preliminary evaluations of the time-dependent signal increase after
contrast administration showed a relatively fast inﬂux of contrast
agent into the DRG tissue. This observation suggested use of the Tofts
model for modeling a concentration time curve to the measured data.
We calculated these parameters for the ROI within the DRG L5 and
S1 and the spinal nerve L5.
Statistical analysis
Data visualization and statistical analyses were performed using
Microsoft Excel. Mean values were calculated for Ktrans and Ve in each
subject for DRG L5 and S1 as well as spinal nerve L5. Bar charts for Ktrans
and Ve were charted in Microsoft Excel.
CBRA and NFRA values of the S1 DRG were charted. Mean values
were tested for statistical signiﬁcance using a Student's t-Test, with a
two-sided alpha level for signiﬁcance of p-value: b0.05. Pearson corre-
lation analysis was performed for age vs. Ktrans/Ve.
Results
Perfusion parametermaps of the DRG and spinal nerveswere gener-
ated (Fig. 3) and quantitatively assessed for a total of 46 participants
(Figs. 4, 5).
DRG Ktrans values were signiﬁcantly increased compared to spinal
nerve L5 (Ktrans = 3.8 ± 1.5 10−3/min vs. 1.6 ± 0.9 10−3/min, p-sis of DRG perfusion. Regions of interest were deﬁnedmanually comprising the DRG L5/S1
ft corner. Quantitative parameter maps were calculated using the Tofts model and yielded
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pared to the spinal nerve L5 (Ve = 38.1 ± 19.2% vs. 17.3 ± 9.9%, p-
value: b0.001, Fig. 4).
Parameters showed no statistically signiﬁcant difference on DRG-
level (L5 vs. S1; p-value: 0.62 (Ktrans); 0.17 (Ve)) and -side (left vs.
right; p-value: 0.25 (Ktrans); 0.79 (Ve)). Females showed a statistically
signiﬁcant increased permeability compared to men (Ktrans = 4.3 ±
1.4 10−3/min vs. 3.4 ± 0.9 10−3/min, p-value: b0.05) whereas intersti-
tial leakage fraction showed no statistically signiﬁcant differences (Ve
female 40.1 ± 14,1% vs. male 34.5 ± 17.4%, p-value: 0.24).
Since peripheral nerves are known to show age-related degenera-
tive changes, correlation analyses between perfusion parameters and
age were performed. No signiﬁcant correlations between age and Ktrans
or Ve were observed.
Quantitative readout parameters (Ktrans and Ve) of the peripheral
zone (CBRA) were compared to the values at the central zone (NFRA)
of the S1 DRG (Fig. 5). In this comparison, the DRG showed a distinct
spatial pattern of distribution of Ktrans and Ve (Fig. 5). Theses parameters
were signiﬁcantly higher in the peripheral zone than in the central zone
(Ktrans = 4.4 ± 1.8 10−3/min vs. 1.7 ± 1.2 10−3/min, p-value: b0.001
and Ve = 40.9 ± 21.3% vs. 15.1 ± 11.7%, p-value: b0.001).
Discussion
In this study we show that DCE MRI can be used to measure
humanDRGperfusion in-vivo by parameters of blood-tissue permeabil-
ity (Ktrans) and interstitial leakage fraction (Ve).
To our knowledge this is the ﬁrst in-vivo investigation of physio-
logic and metabolic human DRG function indicated by quantitativeFig. 3.Perfusion parametermaps in S1DRG. Parametermaps for Ktrans andVe at the level of theD
visual recognition and anatomical orientation (C, D). Ktrans (A) and Ve (B) were calculated using
also allow relatively good differentiation between areaswith high or low values for Ktrans and Ve
values are found in the connective tissue surrounding the DRG, containing the ganglions vascuparameters of DRG perfusion and permeability. The assessed perfu-
sion parameters of blood-tissue permeability (Ktrans) and leakage of
contrast agent into the interstitial space (Ve) were signiﬁcantly
increased in the DRG compared to the spinal nerve.
Additionally, perfusion parameters in the peripheral zone of the
DRG, containing cell bodies of the primary sensory neurons (CBRA),
were signiﬁcantly increased compared to the central NFRA, containing
the incoming and outgoing nerve axons. Interestingly, the perfusion pa-
rameters of the spinal nerve were roughly similar compared to the cen-
tral NFRA in DRG, which may be related to microstructural similarities
and adjacency between these two segments of the PNS (spinal nerve
trunk continuing partly as the ﬁbers entering the DRG). Altogether,
these observations are consistent with former invasive animal studies,
using autoradiographical measurements and immunohistochemical
methods, that revealed a three-fold increase of blood ﬂow within the
DRG compared to peripheral nerve (Sasaki et al., 1997) as well as a
seven-fold blood-vessel-density in the CBRA compared to the NFRA
(Jimenez-Andrade et al., 2008).
Microvascular approaches in animals using light, immunofocal and
electron-microscopy after intravenous injection of tracers have alsopre-
viously shown that the blood vessels of the CBRA have large fenestra-
tions and a relative lack of tight junction proteins compared to the
peripheral nerve (Jacobs, 1978; Anzil et al., 1976; Jacobs et al., 1976),
allowing large molecules to leak out of the CBRA supporting microvas-
culature while remaining intravascularly within the NFRA and the pe-
ripheral nerves (Hirakawa et al., 2004; Jacobs et al., 1976; Arvidson,
1979; Olsson, 1968).
The blood-nerve-barrier in peripheral nerves forms a tight and high-
ly regulated interface similar to the blood-brain-barrier (Weerasuriya &RGS1overlayedwith axial T1-weighted images, showingDRG at high spatial resolution for
the Toftsmodel and are visualized in quantitative parametermaps. These parametermaps
within theDRG, representing the peripheral CBRA and the central NFRA. High Ktrans andVe
lar plexus.
Fig. 4. Perfusion parameters of the L5/S1DRG compared to the spinal nerve L5. Statistical analysis of perfusion parameters of the L5/S1DRG vs. spinal nerve L5. Ktrans (A) aswell as Ve (B) of
the DRG are signiﬁcantly increased compared to the spinal nerve (***p-value: b0.001).
85T. Godel et al. / NeuroImage 141 (2016) 81–87Mizisin, 2011). The speciﬁc purpose of the particular leaky structure of
the DRG blood tissue border and the physiologically elevated leakage
of its microvascular endothelium (Hirakawa et al., 2004) is likely to sat-
isfy the high metabolic demand of sensory cell bodies including thoseFig. 5. Perfusion parameters of the CBRA compared to the NFRA of the S1 DRG. Statistical analysi
the peripheral CBRA is signiﬁcantly increased compared to the central NFRA (***p-value: b0.00that need to support the longest axons innervating the most distal ex-
tremity regions (Devor, 1999). An increased perfusion coupled with
dense vascularization, the lack of tight junction proteins and the pres-
ence of large, endothelial fenestrations may synergistically contributes of perfusion parameters of the CBRA vs. NFRA of the S1 DRG. Ktrans (A) aswell as Ve (B) of
1).
86 T. Godel et al. / NeuroImage 141 (2016) 81–87to an increased vulnerability of primary sensory neurons of the DRG to
neurotoxic agents.
Drug induced neuropathic pain is one of the major side effects of
chemotherapy for example in cancer or HIV-treatment (Pettersen
et al., 2006; Fallon, 2013). It is characterized by numbness, tingling,
burning sensation and cold allodynia (Pain Suppl., 1986). The risk of
neuropathy is proportional to the dose and duration of drug administra-
tion (Lee & Swain, 2006; Seidman et al., 2008). While the cell bodies of
alpha-motoneurons are housed within the tight blood-brain-barrier of
the CNS, the sensory neuron bodies of the DRG are exposed to toxic sub-
stances circulating in the blood. Thismicrostructural feature, speciﬁc for
theDRG, likely explainswhyanti-neoplastic and anti-HIV agents prefer-
ably induce a peripheral sensory polyneuropathy frequently character-
ized by neuropathic pain. Interestingly, the in-vivo morphometric
measurement of the DRG in oxaliplatin induced chemotoxic sensory
and painful distally symmetric polyneuropathy revealed clear signs of
structural degeneration during the course of disease (Bäumer et al.,
2015). This observation further points towards a central and primary
role of the DRG in the pathogenesis particularly of toxic metabolically
induced painful polyneuropathies.
Dose escalation of chemotherapeutic agents (e.g. cisplatin) is fre-
quently necessary to prolong survival in a variety of oncologic condi-
tions (Mielke et al., 2006; Aghajanian et al., 1998; Pasini et al., 2002;
Cocconi et al., 1999). In contrast to neuropathy, other side effects such
as drug-induced hypersensitivity or neutropenia represent treatable
conditions (e.g. by treatment with antihistamines, steroids or granulo-
cyte colony-stimulating factor (Einzig et al., 1998)). However, the
symptoms and the electrophysiological and structural alterations of
chemotherapy induced peripheral neuropathy unfortunately still repre-
sent complications which are currently untreatable, eventually dose
limiting and may lead to discontinuation of chemotherapy (Lee &
Swain, 2006; Quasthoff & Hartung, 2002; Mielke et al., 2006; Pignata
et al., 2006).
In our study female gender was associated with a signiﬁcantly in-
creased vascular permeability within the DRG. Consistent with this ob-
servation, various clinical studies have reported that females may be
more sensitive to chronic and neuropathic pain than males (Ruau
et al., 2012; Hurley & Adams, 2008; Fillingim et al., 2009). Gender differ-
ences in chemotherapy induced neuropathic pain have only been inves-
tigated in animal studies so far, showing contradictory results. While
therewas no gender difference in cisplatin induced cold andmechanical
allodynia, female mice showed an increased sensitivity against cold
allodynia, but not mechanical allodynia in paclitaxel induced
polyneuropathy (Naji-Esfahani et al., 2016). In contrast, another animal
study observed no gender difference in paclitaxel induced neuropathic
pain (Hwang et al., 2012).
The regulation of blood ﬂow into and within the DRG is achieved by
muscular sphincters at strategical locations along the arteriole trunks
and their branchingpoints, to adjustﬂow tovarying functional andmet-
abolic demand (Kobayashi et al., 2010). It is conceivable that DRG not
only adapt vascular supply and blood ﬂow or permeability to functional
variability dependent on short-term activity but also to long-term
changes in neuronal activity or excitability which particularly may
occur in sensory neuropathies and neuropathic pain syndromes (Xiao
et al., 2016; Hogan, 2007; Sapunar et al., 2005; Zhang et al., 2004).
DCE MRI could potentially identify such alterations in DRG perfusion.
The potential clinical relevance of measuring this is indicated by ﬁnd-
ings that increased neuronal excitability may cause or aggravate the
symptoms of human sensory neuropathies including neuropathic pain
(Obata & Noguchi, 2008; Zhao et al., 2015; Malet & Brumovsky, 2015),
oxaliplatin induced toxic sensory neuropathy (Zhao et al., 2012), lum-
bar disc herniation (Yan et al., 2015), or inﬂammatory pain (Malet &
Brumovsky, 2015).
In contrast, metabolic dysfunction also plays a crucial role in the
pathogenesis of diverse pain syndromes. In-vitro animal studies using
electrostimulation demonstrated that DRG are highly sensitive tohypoxia induced by mechanical compression, causing abnormal sensa-
tions and pain in radiculopathy (Sugawara et al., 1996). The painful
symptoms of diabetic neuropathy, which often dominate during the
early stages of this most prevalent human neuropathy, likely result
frommetabolic aberrations leading to biochemical, structural and func-
tional changes in the DRG (Sima & Sugimoto, 1999; Tavee & Zhou,
2009). Animal studies suggest that tissue ischemia and lower ambient
oxygen tension in the DRG due to hyperglycemia may lead to aberrant
metabolic functions and sensory symptoms (Rahman et al., 2016).
Given this wide spectrum of potential relevance, it can be anticipat-
ed that in-vivo methods of measuring aspects of human DRG perfusion
such as the one presented here, will ﬁnd application in the investigation
of the time course and localization of highly prevalent but poorly under-
stood PNS disorders such as drug- ormetabolic-induced peripheral sen-
sory neuropathies and neuropathic pain syndromes. Beyond these
ﬁelds, changes in DRG perfusion most likely play an important role in
low back pain and sciatica in patients with disc herniation and spinal
canal stenosis.
Our study has several limitations. First, it is a limitation of our study
and of any DCEMRI perfusion technique that the absolute values of per-
fusion parameters as reported here needed to be modeled. We chose
the Tofts model for this purpose because it is valid particularly for pa-
rameter estimation in tissues with high vascular permeability. A limita-
tion of the Tofts model is the fact that plasma ﬂow and tissue
permeability cannot be estimated separately. Changes in Ktrans can be
attributed to changes in plasma ﬂow or tissue permeability only if the
ﬂow regime meets certain presuppositions. Second, sequence parame-
ters in DCE-MRI are a compromise between coverage, temporal, and
spatial resolution. Small variations in the arterial input function (AIF)
due to a relatively low temporal resolution does not affect the intra-
individual ratio of perfusion parameters between different levels (S1/
L5) or sides (right/left), but it results in some inter-individual variation
of the absolute perfusion parameters. Third, the normal values present-
ed here may depend to some extent on the sequence parameters cho-
sen, and researchers adopting the technique will have to conﬁrm their
own control values on their scanner system. And fourth, since there is
no possibility to distinguish the central (NFRA) and peripheral (CBRA)
zones in the anatomical image, additional ROIs where drawn by deﬁn-
ing these areas in the acquired Ktrans/Ve maps.Conclusion
The non-invasive and in-vivo measurement of human DRG perfu-
sion is feasible by MRI and shows a substantially higher permeability
and interstitial leakage in the DRG than spinal nerves. Even distinct
physiological perfusion patterns could be observed for different micro-
structural compartments within the DRG. These advances may become
particularly useful for future studies on the poorly understood human
sensory neuropathies and pain syndromes.Disclosure
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